Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer

Cancer Science

Volumn 101, Issue 8, 2010, Pages 1807-1812

  Liu, Qi Sheng ^a   Zhang, Jin ^a   Liu, Meng ^a   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CDH17; GELATINASE A; GELATINASE B; LENTIVIRUS VECTOR; LIVER INTESTINE CADHERIN; MICRORNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL CYCLE ARREST; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR GROWTH; ZYMOGRAPHY;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LENTIVIRUS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 77954853935     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01600.x     Document Type: Article

References (26)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-50.
2. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006, 12:17-20.
3. Grotzinger C, Kneifel J, Patschan D. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 2001, 49:73-81.
4. Dong WG, Yu QF, Xu Y, Fan LF. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. Dig Dis Sci 2008, 53:1811-7.
5. Dong W, Yu Q, Xu Y. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig Dis Sci 2007, 52:536-42.
6. Gessner R, Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann N Y Acad Sci 2000, 915:136-43.
7. Kreft B, Berndorff D, Bottinger A. LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions. J Cell Biol 1997, 136:1109-21.
8. Berndorff D, Gessner R, Kreft B. Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 1994, 125:1353-69.
9. Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 2002, 123:1565-77.
10. Takamura M, Ichida T, Matsuda Y. Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. Cancer Lett 2004, 212:253-9.
11. Kwak JM, Min BW, Lee JH. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum 2007, 50:1873-80.
12. Boo YJ, Park JM, Kim J. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol 2007, 14:1703-11.
13. Takamura M, Sakamoto M, Ino Y. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003, 94:425-30.
14. Boller K, Vestweber D, Kemler R. Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol 1985, 100:327-32.
15. Gumbiner B, Simons K. A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J Cell Biol 1986, 102:457-68.
16. Gumbiner B, Simons K. The role of uvomorulin in the formation of epithelial occluding junctions. Ciba Found Symp 1987, 125:168-86.
17. Wong BW, Luk JM, Ng IO, Hu MY, Liu KD, Fan ST. Identification of liver-intestine cadherin in hepatocellular carcinoma--a potential disease marker. Biochem Biophys Res Commun 2003, 311:618-24.
18. Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin Cancer Res 2005, 11:483-9.
19. Wang XQ, Luk JM, Garcia-Barcelo M. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma. Clin Cancer Res 2006, 12:5248-52.
20. Takamura M, Sakamoto M, Ino Y. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003, 94(5):425-30.
21. Ito R, Oue N, Yoshida K. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 2005, 447(4):717-22. Epub 2005 Oct 19
22. Ding ZB, Shi YH, Zhou J. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer 2009, 115:4753-65.
23. Liu LX, Lee NP, Chan VW. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 2009, 50:1453-63.
24. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000, 6:4823-30.
25. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001, 7:14-23.
26. Takamura M, Yamagiwa S, Wakai T. Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor. Int J Oncol 2010, 36:245-54.